Explore the CMS disclosure requirements driving payer risk and compliance exposure. And how to align governance, vendors, and validation before penalties hit.
Discover evidence-based screening protocols and intervention strategies for suicide prevention in healthcare settings. Learn how to identify at-risk patients early and connect them to crucial behavioral health support.
HHS has finalized a rule (HTI-4) to deliver real-time prescription drug price transparency at the point of care, giving clinicians and consumers visibility into patient-specific coverage, out-of-pocket costs, and prior authorization requirements through certified health IT. The move aims to reduce administrative burden, speed access to therapy, and support more cost-effective prescribing aligned with value-based care goals.
Prepare for the fall flu season by planning early vaccination campaigns. This guide offers strategies for focusing on high-risk populations.
Explore how gold carding reduces the burden of prior authorization for healthcare providers by rewarding consistent, guideline-adherent care.
HHS and CMS are creating the Healthcare Advisory Committee, a group of experts tasked with providing strategic recommendations directly to HHS Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz.
The goal: improve how care is financed and delivered across Medicare, Medicaid, CHIP, and the Health Insurance Marketplace, while reducing red tape and putting patients first.
Explore targeted immunization initiatives aimed at closing vaccination gaps in underserved populations, emphasizing the importance of payer and provider collaboration.
Learn how electronic prior authorization (ePA) transforms healthcare by replacing manual workflows, improving provider experience, and supporting FHIR API compliance.
Explore effective strategies to combat vaccine hesitancy through clear communication and community engagement initiatives.
The Centers for Medicare & Medicaid Services’ (CMS) WISeR model (originally designed to streamline utilization management and prior authorization processes) is facing renewed attention from lawmakers. A bipartisan congressional letter sent to CMS questions the agency’s legal authority to apply the model to traditional Medicare and warns of potential impacts on beneficiary access, provider operations, and program compliance. As the healthcare industry awaits CMS’ response, payer and provider organizations should prepare for possible policy adjustments that could affect authorization workflows, clinical operations, and financial performance.
